Invention Grant
- Patent Title: Lyophilized viral formulations
-
Application No.: US14693100Application Date: 2015-04-22
-
Publication No.: US09610352B2Publication Date: 2017-04-04
- Inventor: Matthew C. Coffey , Sarah Serl , Leo Pavliv
- Applicant: Oncolytics Biotech Inc.
- Applicant Address: CA Calgary, Alberta
- Assignee: Oncolytics Biotech Inc.
- Current Assignee: Oncolytics Biotech Inc.
- Current Assignee Address: CA Calgary, Alberta
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K47/26
- IPC: A61K47/26 ; A61K9/19 ; A61K47/02 ; A61K47/18 ; A61K9/00 ; C12N7/00 ; A61K35/76 ; A61K35/00 ; A61K35/765 ; A61K35/768

Abstract:
Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The lyophilized viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
Public/Granted literature
- US20150224198A1 LYOPHILIZED VIRAL FORMULATIONS Public/Granted day:2015-08-13
Information query
IPC分类: